Key Opinion Leaders participating will be Stuart Goldstein, MD, Cincinnati Children’s Hospital and Lakhmir Chawla, MD, former Chief of the Division of.
/PRNewswire/ AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative.
CKD Hospitalization Patterns May Predict ESKD, Death Risks - Renal and Urology News renalandurologynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from renalandurologynews.com Daily Mail and Mail on Sunday newspapers.
CINCINNATI, Feb. 18, 2021 /PRNewswire/ Cincinnati Children’s Hospital Medical Center has begun treating critically ill infants in renal failure with a new device designed to improve the outcomes for smaller, fragile babies.
The Cardio-Renal Pediatric Dialysis Emergency Machine (CARPEDIEM) is a new system for patients with acute kidney injury or kidney failure requiring dialysis. This ground-breaking technology is intended to provide continuous renal replacement therapy (CRRT) to patients weighing between 5 and 20 pounds.
ADVERTISEMENT
Medtronic, the medical device manufacturer, received authorization last year from the Food and Drug Administration (FDA). Stuart Goldstein, MD, director of the Center for Acute Care Nephrology at Cincinnati Children’s, was a clinical consultant in developing the device.